Clinical Trial Update: A Long-term Follow-up Study in Patients Who Received BEAM-101

View source ↗

Summary

A long-term follow-up study of patients who received BEAM-101 is ongoing, with the trial currently recruiting to assess long-term outcomes in hemoglobinopathies…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobinopathy
• Sickle Cell Disease

Drugs mentioned

• BEAM-101

Snippet

Sponsor: Beam Therapeutics Inc. | Conditions: Hemoglobinopathy, Sickle Cell Disease | Status: RECRUITING